Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $2.97 Million - $3.75 Million
-129,130 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $443,708 - $532,663
-17,720 Reduced 12.07%
129,130 $3.6 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $58,288 - $69,487
-2,125 Reduced 1.43%
146,850 $4.31 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $826,570 - $1.33 Million
-38,679 Reduced 20.61%
148,975 $4.72 Million
Q4 2020

Feb 12, 2021

SELL
$15.31 - $21.12 $1.02 Million - $1.4 Million
-66,471 Reduced 26.16%
187,654 $3.77 Million
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $650,092 - $879,459
43,689 Added 20.76%
254,125 $3.8 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $41,287 - $63,622
3,102 Added 1.5%
210,436 $3.84 Million
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $315,946 - $736,315
24,341 Added 13.3%
207,334 $3.15 Million
Q4 2019

Feb 13, 2020

SELL
$18.89 - $31.89 $25,180 - $42,509
-1,333 Reduced 0.72%
182,993 $5.42 Million
Q3 2019

Nov 13, 2019

SELL
$20.88 - $25.66 $1.54 Million - $1.9 Million
-73,862 Reduced 28.61%
184,326 $4 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $683,952 - $881,604
-33,331 Reduced 11.43%
258,188 $6.42 Million
Q1 2019

May 15, 2019

BUY
$20.23 - $26.29 $2.73 Million - $3.55 Million
134,914 Added 86.15%
291,519 $7.19 Million
Q4 2018

Feb 13, 2019

SELL
$17.64 - $28.32 $764,323 - $1.23 Million
-43,329 Reduced 21.67%
156,605 $2.94 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $4.13 Million - $5.13 Million
199,934 New
199,934 $5.06 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.88B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.